Sales Rep Portal
Everything you need to sell Junera
Clinical evidence, competitive intelligence, sales scripts, training videos, and downloadable materials — all in one place.
Why Junera
The Competitive Advantage
Single-Session Results
Clinically significant improvement in one treatment — no repeat visits. Results develop over 3–6 months as collagen remodeling occurs.
Measurable Outcomes
48.75% dermis density increase, 53.78% wrinkle volume decrease, and 80–100% patient satisfaction documented across 15+ peer-reviewed studies.
Zero Serious Adverse Events
Confirmed across a systematic review of 31 studies. Real-time thermal monitoring keeps surface temperature below 40°C.
Resources
Your Sales Toolkit
Organized by category — drag cards to reorder your layout
Product Knowledge
Understand the science, master the conversation
Sales Tools
Close with confidence, backed by data
Marketing Materials
Ready-to-use assets for practice growth
For internal Onyxa Medical sales team use only. Not for distribution to patients or the general public. Individual results may vary. Clinical statistics cited from published peer-reviewed studies. Junera is cleared under FDA 510(k) K212734 for soft tissue coagulation and ablation. The Junera procedure is defined as subdermal laser tissue remodeling.